Skip to content

Influence of supracrestal tissue height to early stage bone resorption and probing depth of platform switch implants: A prospective cohort study

Influence of supracrestal tissue height to early stage bone resorption and probing depth of platform switch implants: A prospective cohort study

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052381
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arch defect

Interventions

thin mucosa group:implant therapy
think mucosa group:implant therapy
excessive think mucosa group:implant therapy

Sponsors

Peking University Hospital and School of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient criteria: (1) Aged over 18 years old; (2) General health; (3) No systemic diseases that may affect bone metabolism and wound healing; (4) Willing to cooperate with research follow-up and good compliance; (5) Sign the informed consent; 2. Planting site standard: (1) For premolars and molars, the alveolar ridge is healed after tooth extraction for more than 6 months; (2) There is a keratinized mucosa to meet the requirement of a keratinized mucosa with a width of at least 3 mm on the buccal side after implantation; (3) The buccal and lingual diameter of the bone crest shown by CBCT is at least 7mm, and the bone height from the crest to the mandibular neural canal, mental foramen, maxillary sinus floor and other anatomical structures is at least 5mm; (4) The extraction site was not preserved or other bone augmentation methods were used before implantation; (5) The presence of opposing teeth.

Exclusion criteria

Exclusion criteria: 1. History of head and neck radiotherapy; 2. Are or have been taking orally or injecting bisphosphonates; 3. Poor blood sugar control (glycated hemoglobin greater than 7.5%); 4. Smokers or those with a history of smoking; 5. Untreated periodontal disease; 6. Poor oral hygiene (full mouth probing bleeding index greater than 30%, full mouth plaque index greater than 30%); 7. Alcohol/drug abuse; 8. Patients with missing dentition; 9. The implant placement torque is less than 15Ncm.

Design outcomes

Primary

MeasureTime frame
probing depth;marginal bone loss;

Secondary

MeasureTime frame
bleeding on prbing;complications;keratinized mucosa width;recession;alveolar bone width;Gingival index;plaque index;

Countries

China

Contacts

Public ContactZhang Haidong

Peking University Hospital and School of Stomatology

siegfriedzhang@126.com+86 13426305500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026